Streptococcus and isoflavone-containing composition
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsShigeto Uchiyama, Tomomi Ueno, Megumi Kumemura, Kiyoko Imaizumi, Kyosuke Masaki, Seiichi Shimizu
Life of this patent
Estimating the term…
Abstract
This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinical syndrome inclusive of menopausal syndrome in middle-aged to elderly woman for which no effective means of prevention or alleviation has heretofore been available.
Claims8
A composition comprising a daidzein-containing substance, at least one strain of a live microorganism capable of metabolizing daidzein to equol and at least one component that favors the maintenance and growth of the strain as essential ingredients, wherein said strain is selected from the group consisting of Streptococcus E-23-17, which has been deposited as FERM BP-6436, and Streptococcus A6G-225, which has been deposited as FERM BP-6437.
Dependencies are inferred from the claim text.